Bharat Biotech's TB Vaccine, one of India's leading biopharmaceutical businesses, has started clinical trials for its TB vaccine, MTBVAC, throughout the nation, marking a significant advancement in the fight against tuberculosis (TB). This ground-breaking action represents an important turning point in the fight against tuberculosis (TB), a disease that continues to be a major worldwide health concern. Let's examine this ground-breaking discovery's specifics and their ramifications.